Application Note: WB: 1:500-1:2000. IHC-P: 1:100-1:500. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Calculated MW: 21
Form: Liquid
Buffer (with preservative): 0.01M TBS (pH7.4), 1% BSA, 50% glycerol, 0.03% Proclin300.
Concentration: 1 mg/ml (Please refer to the vial label for the specific concentration.)
Background: Predicted to enable actin binding activity and myosin binding activity. Predicted to be a structural constituent of myelin sheath. Predicted to be involved in nervous system development. Predicted to be located in mitochondrion. Predicted to be active in cortical actin cytoskeleton. Implicated in frontotemporal dementia. [provided by Alliance of Genome Resources, Nov 2021]
Uniprot ID: Q13875
Antigen Species: Human
Immunogen: KLH conjugated synthetic peptide derived from human MOBP (7-90).
Purification: Protein A purified
Conjugation: Unconjugated
Full Name: myelin associated oligodendrocyte basic protein
English
Deutsch
